Alexander Gottstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander Gottstein has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Saverio Braccini
Albert Einstein Center for Fundamental Physics (AEC), Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse 5, CH-3012 Bern, Switzerland
5 shared publications - Eva Kasanda
Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics, Universität Bern, Sidlerstrasse 5, 3012 Bern
4 shared publications - Isidre Mateu
Albert Einstein Center for Fundamental Physics (AEC), Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse 5, CH-3012 Bern, Switzerland
4 shared publications - Lars Eggimann
Albert Einstein Center for Fundamental Physics (AEC), Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse 5, CH-3012 Bern, Switzerland
4 shared publications - Paola Scampoli
Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics, University of Bern, Sidlerstrasse 5, CH-3012 Bern, Switzerland
4 shared publications Gaia Dellepiane
3 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 236, 112727
Cross-section measurements of lanthanum radioisotopes towards an optimized production of 133La and 135La for theranostic applications
- 1 June 2026
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 236, 112727
Open AccessCross-section measurements of lanthanum radioisotopes towards an optimized production of 133La and 135La for theranostic applications
- Open Access
- 12 March 2026
- Published by Elsevier in SSRN Electronic Journal
Cross-section measurements of lanthanum radioisotopes towards an optimized production of 133La and 135La for theranostic applications
The theranostic pair 133La/135La has recently attracted growing interest as a promising candidate for combined diagnostic and therapeutic applications, owing to the favorable nuclear and chemical properties of lanthanum. 135La (t1/2 = 18.91 h) decays by electron capture (EC) to the ground state of 135Ba, emitting Auger cascade electrons that are potentially useful for targeted internal radiotherapy. In contrast, 133La (t1/2 = 3.912 h) is a β+-emitter suitable for PET imaging. Moreover, 133La has been proposed as a diagnostic partner for 225Ac (t1/2 = 9.9 d), due to their close chemical similarity and the longer half-life of 133La compared with other PET radiometals such as 68Ga (t1/2 = 1.13 h).A feasible approach for producing 133La and 135La is the irradiation of enriched 134Ba and 135Ba targets, respectively, with low- to medium-energy proton beams (up to 25 MeV maximal energy) readily available from medical cyclotrons. Although these production routes have been previously explored, the available nuclear data on lanthanum radioisotopes remain limited and often inconsistent. In this work, we measured the cross sections of reactions producing lanthanum isotopes up to 18 MeV, using natural BaCO3 as well as enriched 134BaCO3 and 135BaCO3 targets, with some cross sections reported here for the first time. The half-lives of La radioisotopes were also determined and compared with the literature values. The resulting data were used to optimize the production parameters for 1La and 135La, and several irradiation tests were carried out to validate our findings.
- 12 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessCross-section measurements of lanthanum radioisotopes towards an optimized production of 133La and 135La for theranostic applications
The theranostic pair 133La/135La has recently attracted growing interest as a promising candidate for combined diagnostic and therapeutic applications, owing to the favorable nuclear and chemical properties of lanthanum. 135La (t1/2 = 18.91 h) decays by electron capture (EC) to the ground state of 135Ba, emitting Auger cascade electrons that are potentially useful for targeted internal radiotherapy. In contrast, 133La (t1/2 = 3.912 h) is a β+-emitter suitable for PET imaging. Moreover, 133La has been proposed as a diagnostic partner for 225Ac (t1/2 = 9.9 d), due to their close chemical similarity and the longer half-life of 133La compared with other PET radiometals such as 68Ga (t1/2 = 1.13 h).A feasible approach for producing 133La and 135La is the irradiation of enriched 134Ba and 135Ba targets, respectively, with low- to medium-energy proton beams (up to 25 MeV maximal energy) readily available from medical cyclotrons. Although these production routes have been previously explored, the available nuclear data on lanthanum radioisotopes remain limited and often inconsistent. In this work, we measured the cross sections of reactions producing lanthanum isotopes up to 18 MeV, using natural BaCO3 as well as enriched 134BaCO3 and 135BaCO3 targets, with some cross sections reported here for the first time. The half-lives of La radioisotopes were also determined and compared with the literature values. The resulting data were used to optimize the production parameters for 1La and 135La, and several irradiation tests were carried out to validate our findings.
- Open Access
- 1 March 2026
- Published by IOP Publishing in Journal of Instrumentation
- Vol. 21 (03) , P03036
Non-destructive beam monitoring via secondary radiation detection with Ce-doped silica fibers
Non-destructive beam diagnostics are essential for low-energy medical cyclotrons, where even thin interceptive devices can severely degrade beam quality. We investigate an external fiber monitor (EFM) based on Ce-doped silica scintillating fibers that detects secondary radiation generated at existing beamline components of the 18 MeV Bern Medical Cyclotron beam transfer line (BTL). Three use cases were studied: (i) beam intensity monitoring around an electrically isolated, water-cooled beam dump; (ii) beam-loss monitoring around a 10 mm collimator under varying the beam focusing; and (iii) by steering a 6×6 mm beam spot on a beam dump. For case (i), the summed EFM signal exhibits a linear dependence on the current on target over nearly three orders of magnitude. In case (ii), a normalized EFM-based beam-loss proxy scales monotonically with an electrical loss proxy across several focusing settings. Furthermore, opposing-fiber signal ratios provide decoupled, monotonic sensitivity to horizontal and vertical beam displacements.
- 1 March 2026
- Published by IOP Publishing in Journal of Instrumentation
- Vol. 21 (03) , P03036
Open AccessNon-destructive beam monitoring via secondary radiation detection with Ce-doped silica fibers
Non-destructive beam diagnostics are essential for low-energy medical cyclotrons, where even thin interceptive devices can severely degrade beam quality. We investigate an external fiber monitor (EFM) based on Ce-doped silica scintillating fibers that detects secondary radiation generated at existing beamline components of the 18 MeV Bern Medical Cyclotron beam transfer line (BTL). Three use cases were studied: (i) beam intensity monitoring around an electrically isolated, water-cooled beam dump; (ii) beam-loss monitoring around a 10 mm collimator under varying the beam focusing; and (iii) by steering a 6×6 mm beam spot on a beam dump. For case (i), the summed EFM signal exhibits a linear dependence on the current on target over nearly three orders of magnitude. In case (ii), a normalized EFM-based beam-loss proxy scales monotonically with an electrical loss proxy across several focusing settings. Furthermore, opposing-fiber signal ratios provide decoupled, monotonic sensitivity to horizontal and vertical beam displacements.
- Open Access
Non-Destructive Beam Monitoring via Secondary Radiation Detection with Ce-Doped Silica Fibers
Non-destructive beam diagnostics are essential for low-energy medical cyclotrons, where even thin interceptive devices can severely degrade beam quality. We investigate an external fiber monitor (EFM) based on Ce-doped silica scintillating fibers that detects secondary radiation generated at existing beamline components of the 18 MeV Bern Medical Cyclotron beam transfer line (BTL). Three use cases were studied: (i) beam intensity monitoring around an electrically isolated, water-cooled beam dump; (ii) beam-loss monitoring around a 10 mm collimator under varying the beam focusing; and (iii) by steering a 6.5 mm $\times$ 6.5 mm beam spot on a beam dump. For case (i), the summed EFM signal exhibits a linear dependence on the current on target over nearly three orders of magnitude. In case (ii), a normalized EFM-based beam-loss proxy scales monotonically with an electrical loss proxy across several focusing settings. Furthermore, opposing-fiber signal ratios provide decoupled, monotonic sensitivity to horizontal and vertical beam displacements.Open AccessNon-Destructive Beam Monitoring via Secondary Radiation Detection with Ce-Doped Silica Fibers
Non-destructive beam diagnostics are essential for low-energy medical cyclotrons, where even thin interceptive devices can severely degrade beam quality. We investigate an external fiber monitor (EFM) based on Ce-doped silica scintillating fibers that detects secondary radiation generated at existing beamline components of the 18 MeV Bern Medical Cyclotron beam transfer line (BTL). Three use cases were studied: (i) beam intensity monitoring around an electrically isolated, water-cooled beam dump; (ii) beam-loss monitoring around a 10 mm collimator under varying the beam focusing; and (iii) by steering a 6.5 mm $\times$ 6.5 mm beam spot on a beam dump. For case (i), the summed EFM signal exhibits a linear dependence on the current on target over nearly three orders of magnitude. In case (ii), a normalized EFM-based beam-loss proxy scales monotonically with an electrical loss proxy across several focusing settings. Furthermore, opposing-fiber signal ratios provide decoupled, monotonic sensitivity to horizontal and vertical beam displacements. - Open Access
- 19 December 2025
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1084
Beam energy measurement using a Bayesian approach with the stacked foil method
- 19 December 2025
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1084
Open AccessBeam energy measurement using a Bayesian approach with the stacked foil method
- Open Access
- 4 November 2022
- Published by American Physical Society (APS) in Physical Review Letters
- Vol. 129 (19) , 191801
New Limit on Axionlike Dark Matter Using Cold Neutrons
We report on a search for dark matter axionlike particles (ALPs) using a Ramsey-type apparatus for cold neutrons. A hypothetical ALP-gluon coupling would manifest in a neutron electric dipole moment signal oscillating in time. Twenty-four hours of data have been analyzed in a frequency range from to 1 kHz, and no significant oscillating signal has been found. The usage of present dark-matter models allows one to constrain the coupling of ALPs to gluons in the mass range from to . The best limit of (95% C.L.) is reached in the mass range from to .- 4 November 2022
- Published by American Physical Society (APS) in Physical Review Letters
- Vol. 129 (19) , 191801
Open AccessNew Limit on Axionlike Dark Matter Using Cold Neutrons
We report on a search for dark matter axionlike particles (ALPs) using a Ramsey-type apparatus for cold neutrons. A hypothetical ALP-gluon coupling would manifest in a neutron electric dipole moment signal oscillating in time. Twenty-four hours of data have been analyzed in a frequency range from to 1 kHz, and no significant oscillating signal has been found. The usage of present dark-matter models allows one to constrain the coupling of ALPs to gluons in the mass range from to . The best limit of (95% C.L.) is reached in the mass range from to . - Open Access
New Limit on Axion-Like Dark Matter using Cold Neutrons
We report on a search for dark matter axion-like particles (ALPs) using a Ramsey-type apparatus for cold neutrons. A hypothetical ALP-gluon-coupling would manifest in a neutron electric dipole moment signal oscillating in time. Twenty-four hours of data have been analyzed in a frequency range from 23 $\mu$Hz to 1 kHz, and no significant oscillating signal has been found. The usage of present dark-matter models allows to constrain the coupling of ALPs to gluons in the mass range from $10^{-19}$ to $4 \times 10^{-12}$ eV. The best limit of $C_G$/$f_a m_a = 2.7 \times 10^{13}$ GeV$^{-2}$ (95% C.L.) is reached in the mass range from $2 \times 10^{-17}$ to $2 \times 10^{-14}$ eV.Open AccessNew Limit on Axion-Like Dark Matter using Cold Neutrons
We report on a search for dark matter axion-like particles (ALPs) using a Ramsey-type apparatus for cold neutrons. A hypothetical ALP-gluon-coupling would manifest in a neutron electric dipole moment signal oscillating in time. Twenty-four hours of data have been analyzed in a frequency range from 23 $\mu$Hz to 1 kHz, and no significant oscillating signal has been found. The usage of present dark-matter models allows to constrain the coupling of ALPs to gluons in the mass range from $10^{-19}$ to $4 \times 10^{-12}$ eV. The best limit of $C_G$/$f_a m_a = 2.7 \times 10^{13}$ GeV$^{-2}$ (95% C.L.) is reached in the mass range from $2 \times 10^{-17}$ to $2 \times 10^{-14}$ eV. - Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Optimised Production of 67Cu Based on Cross-Section Measurements of 67Cu and 64Cu Using an 18 Mev Medical Cyclotron
RadioNuclide Therapy (RNT) in nuclear medicine is a cancer treatment based on the administration of radioactive substances that specifically target diseased cells in the patient. These radiopharmaceuticals consist of tumor-targeting vectors labelled with β-, α, or Auger electron–emitting radionuclides. In this framework, 67Cu is receiving increasing interest as it provides β--particles accompanied by low-energy gamma radiation. The latter allows to perform Single Photon Emission Tomography (SPECT) imaging for detecting the radiotracer distribution for an optimised treatment plan and follow-up. Furthermore, 67Cu could be used as therapeutic partner of the β+-emitters 61Cu and 64Cu, both currently under study for Positron Emission Tomography (PET) imaging, paving the way to the concept of theranostics. The major barrier to a wide use of 67Cu-based radiopharmaceutical is its lack of availability in quantities and qualities suitable for clinical applications.A possible but challenging solution is the proton irradiation of enriched 70Zn targets, using medical cyclotrons equipped with a solid target station. This route was investigated at the Bern medical cyclotron, where an 18 MeV medical cyclotron is in operation together with a solid target station and a 6-m-long beam transfer line.The cross section of the involved nuclear reactions were accurately measured to optimise the production yield and the radionuclidic purity. In particular, 64Cu was experimentally observed for the first time in the production route and energy range investigated. Several production tests were performed to confirm the obtained results.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessOptimised Production of 67Cu Based on Cross-Section Measurements of 67Cu and 64Cu Using an 18 Mev Medical Cyclotron
RadioNuclide Therapy (RNT) in nuclear medicine is a cancer treatment based on the administration of radioactive substances that specifically target diseased cells in the patient. These radiopharmaceuticals consist of tumor-targeting vectors labelled with β-, α, or Auger electron–emitting radionuclides. In this framework, 67Cu is receiving increasing interest as it provides β--particles accompanied by low-energy gamma radiation. The latter allows to perform Single Photon Emission Tomography (SPECT) imaging for detecting the radiotracer distribution for an optimised treatment plan and follow-up. Furthermore, 67Cu could be used as therapeutic partner of the β+-emitters 61Cu and 64Cu, both currently under study for Positron Emission Tomography (PET) imaging, paving the way to the concept of theranostics. The major barrier to a wide use of 67Cu-based radiopharmaceutical is its lack of availability in quantities and qualities suitable for clinical applications.A possible but challenging solution is the proton irradiation of enriched 70Zn targets, using medical cyclotrons equipped with a solid target station. This route was investigated at the Bern medical cyclotron, where an 18 MeV medical cyclotron is in operation together with a solid target station and a 6-m-long beam transfer line.The cross section of the involved nuclear reactions were accurately measured to optimise the production yield and the radionuclidic purity. In particular, 64Cu was experimentally observed for the first time in the production route and energy range investigated. Several production tests were performed to confirm the obtained results.